Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» desmoid tumors
desmoid tumors
5 Highly Anticipated FDA Decisions for Rare Diseases Coming This Year
BioSpace
Fri, 07/28/23 - 11:46 am
Ipsen
palovarotene
fibrodysplasia ossificans progressiva
Regeneron
CHAPLE disease
pozelimab
Biomarin
Voxzogo
achondroplasia
Santhera Pharmaceuticals
vamorolone
DMD
Springworks
nirogacestat
desmoid tumors
Pfizer spinout SpringWorks gets FDA priority review for lead drug
Endpoints
Mon, 02/27/23 - 10:14 am
SpringWorks Therapeutics
Pfizer
nirogacestat
desmoid tumors
FDA
priority review
ESMO 2022 – Springworks aims to Defi expectations
EP Vantage
Mon, 09/12/22 - 10:31 am
ESMO
desmoid tumors
GSK
SpringWorks, Eli Lilly and More Release Data Ahead of ESMO
BioSpace
Thu, 09/8/22 - 04:30 pm
SpringWorks Therapeutics
nirogacestat
desmoid tumors
Eli Lilly
ESMO
Pfizer spinout SpringWorks will ship its first drug to the FDA before year’s end with PhIII win
Endpoints
Tue, 05/24/22 - 10:46 am
Pfizer
SpringWorks Therapeutics
spinoffs
oncology
FDA
clinical trials
nirogacestat
desmoid tumors